NO170834C - Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel - Google Patents

Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel

Info

Publication number
NO170834C
NO170834C NO840248A NO840248A NO170834C NO 170834 C NO170834 C NO 170834C NO 840248 A NO840248 A NO 840248A NO 840248 A NO840248 A NO 840248A NO 170834 C NO170834 C NO 170834C
Authority
NO
Norway
Prior art keywords
delivery
procedure
preparation
useful medicine
osmose device
Prior art date
Application number
NO840248A
Other languages
English (en)
Other versions
NO170834B (no
NO840248L (no
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO170834(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO840248L publication Critical patent/NO840248L/no
Publication of NO170834B publication Critical patent/NO170834B/no
Publication of NO170834C publication Critical patent/NO170834C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO840248A 1983-05-11 1984-01-24 Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel NO170834C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (3)

Publication Number Publication Date
NO840248L NO840248L (no) 1984-11-12
NO170834B NO170834B (no) 1992-09-07
NO170834C true NO170834C (no) 1992-12-16

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840248A NO170834C (no) 1983-05-11 1984-01-24 Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel

Country Status (20)

Country Link
JP (1) JPS6041609A (no)
AT (1) AT397180B (no)
AU (1) AU566110B2 (no)
BE (1) BE898819A (no)
CA (1) CA1222950A (no)
CH (1) CH669329A5 (no)
DE (1) DE3417113A1 (no)
DK (1) DK163910C (no)
ES (1) ES532018A0 (no)
FR (1) FR2545721B1 (no)
GB (1) GB2140687B (no)
IE (1) IE56515B1 (no)
IL (1) IL71727A (no)
IT (1) IT1178911B (no)
MX (1) MX163518B (no)
NL (1) NL192250C (no)
NO (1) NO170834C (no)
NZ (1) NZ206600A (no)
SE (1) SE455918B (no)
ZA (1) ZA842422B (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JP2701977B2 (ja) * 1990-09-28 1998-01-21 ファイザー インク 疎水性媒体を含有する投薬体
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
EP0612519B1 (en) * 1993-02-23 2001-04-04 Wolfgang Dr. Werner Use of a calcium formulation in a medicament for therapeutic application to milk cows suffering from hypocalcaemia
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
WO2002036099A1 (en) * 2000-10-30 2002-05-10 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
BRPI0616801B8 (pt) 2005-10-04 2021-05-25 Bayer Healthcare Ag "forma polimórfica de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida, seus processos de preparação e seus usos, medicamento, e processo para prevenção de coagulação de sangue in vitro
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010139111A1 (en) * 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
EP2846777B1 (en) 2012-05-07 2016-10-26 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
BR112020026644A2 (pt) 2018-07-24 2021-03-23 Bayer Aktiengesellschaft Forma de dosagem farmacêutica que pode ser administrada oralmente e tem liberação modificada
WO2020020790A1 (de) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
NO170834B (no) 1992-09-07
MX163518B (es) 1992-05-25
JPH0575725B2 (no) 1993-10-21
CA1222950A (en) 1987-06-16
IE56515B1 (en) 1991-08-28
NL192250B (nl) 1996-12-02
AT397180B (de) 1994-02-25
GB8334189D0 (en) 1984-02-01
FR2545721B1 (fr) 1987-11-06
ZA842422B (en) 1984-11-28
DK99784D0 (da) 1984-02-24
AU2251183A (en) 1984-11-15
FR2545721A1 (fr) 1984-11-16
DK99784A (da) 1984-11-12
JPS6041609A (ja) 1985-03-05
SE8402512L (sv) 1984-11-12
SE455918B (sv) 1988-08-22
ES8503503A1 (es) 1985-03-01
AU566110B2 (en) 1987-10-08
DK163910B (da) 1992-04-21
DE3417113C2 (no) 1989-02-02
ES532018A0 (es) 1985-03-01
DK163910C (da) 1992-09-14
ATA88084A (de) 1993-07-15
NL8401470A (nl) 1984-12-03
BE898819A (fr) 1984-05-30
GB2140687B (en) 1987-03-18
IL71727A0 (en) 1984-09-30
DE3417113A1 (de) 1984-11-15
NZ206600A (en) 1987-01-23
GB2140687A (en) 1984-12-05
IE840010L (en) 1984-11-11
IT8467283A0 (it) 1984-03-23
IT8467283A1 (it) 1985-09-23
NO840248L (no) 1984-11-12
IL71727A (en) 1989-01-31
IT1178911B (it) 1987-09-16
NL192250C (nl) 1997-04-03
CH669329A5 (no) 1989-03-15
SE8402512D0 (sv) 1984-05-09

Similar Documents

Publication Publication Date Title
NO170834C (no) Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
NO170667C (no) Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel
DK464383D0 (da) Medikamentadministreringsapparat
IT1169806B (it) Dispositivo per la somministrazione controllata di farmaci
NO863670L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO840709L (no) Utleveringsinnretning for pastaformede produkter
NO822556L (no) Fremgangsmaate for fremstilling av inhaleringslegemidler
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
NO170792C (no) Anordning til avlufting av vaeske
ZA81706B (en) Device for the administration of medicaments
NO810133L (no) Fremgangsmaate for fremstilling av et avfoeringsmiddel.
FI824098A0 (fi) Terapeutiskt medel
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK313281A (da) Anordning til indgift af medicinsk aktive substanser
NO841492L (no) Fremgangsmaate for anriking av fosforitt
NO159101C (no) Fremgangsmaate for fremstilling av en broennbehandlingsvaeske
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK164771C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk praeparat indeholdende ergot-cycliske peptidalkaloider
DE3483347D1 (de) Intravenoese heilmittelverabreichungsvorrichtung.
FI820999L (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara kefalosporinderivat
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN